openPR Logo
Press release

Lewy Body Dementia Treatment Market Size, Share, Growth Analysis, Business Insights And Forecast To 2033

07-29-2024 11:31 AM CET | Health & Medicine

Press release from: The Business Research Company

Lewy Body Dementia Treatment Market Size

Lewy Body Dementia Treatment Market Size

"The new report published by The Business Research Company, titled ""Lewy Body Dementia Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The lewy body dementia treatment market size is expected to see strong growth in the next few years. It will grow to $5.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9387&type=smp

Surging Brain Disorder Prevalence Fuels Lewy Body Dementia Treatment Market
The rising prevalence of brain-related disorders is expected to propel the growth of the lewy body dementia treatment market going forward. Brain disorders refer to any disorder that impairs brain function. The impairment can be mild, moderate, or severe, depending on the extent of brain damage. Lewy body dementia treatment is used to treat brain disorders such as hallucinations, confusion, and drowsiness by increasing brain chemicals to improve alertness and cognition. For instance, in January 2022, according to a report shared by the American Heart Association Inc., a US-based nonprofit voluntary organization, brain disorders are expected to increase to 9.3 million in the US by 2060, and currently, this number is growing in the US. And one in every six people worldwide suffers from a brain disease. Currently, 1 billion people will suffer from brain disorders worldwide by 2021. Therefore, the rising prevalence of brain-related disorders is driving the growth of the lewy body dementia treatment market.

Innovative Medicine In Lewy Body Dementia Treatment Market
Product innovation is a key trend gaining popularity in the lewy body dementia treatment market. Major companies operating in lewy body dementia treatment are focused on developing innovative solutions to strengthen their position in the market. For instance, in January 2023, Biogen Inc., a US-based multinational biotechnology company, developed its new medicine, lecanemab, which is a humanised monoclonal antibody. This medicine is used to treat Alzheimer's disease, which is part of the disease in Lewy body dementia. The main unique benefit of lecanemab is that it reduces the levels of brain amyloid. It treats the brain and clears the amyloid plaques thought to cause cognitive impairment and dementia in Alzheimer's disease.

The lewy body dementia treatment market covered in this report is segmented -

1) By Drug Type: Antidepressants, Antipsychotic Drugs, Benzodiazepine, Carbidopa-Levodopa, Cholinesterase inhibitors, Modafinil
2) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Alzheimer's disease, Dementia, Parkinson's disease

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9387&type=discount

Major companies operating in the lewy body dementia treatment market report are Mallinckrodt Pharmaceuticals Co., BioArctic AB, Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals Inc., Allergan plc, Novartis International AG, Pfizer Inc., Bayer AG, Amneal Pharmaceuticals LLC., Boehringer Ingelheim International GmbH., Merck & Co. Inc., Abbott Ltd., B Braun SE, Biogen Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., Blairex Laboratories Inc., Blink Health LLC, Blueprint Medicines Corporation, Bristol Myers Squibb Company, Calliditas Therapeutics AB, Catalyst Pharmaceuticals Inc., Chiesi USA Inc., Clovis Oncology Inc., Coherus Biosciences Inc., CooperSurgical Inc., Covis Pharmaceuticals Inc., Genzyme Corporation, GlaxoSmithKline plc, Eisai Co. Ltd., Bausch Health Companies Inc., Hisamitsu Pharmaceutical Co. Inc., Lundbeck Inc. .

Contents of the report:
1. Executive Summary
2. Lewy Body Dementia Treatment Market Report Structure
3. Lewy Body Dementia Treatment Market Trends And Strategies
4. Lewy Body Dementia Treatment Market - Macro Economic Scenario
5. Lewy Body Dementia Treatment Market Size And Growth
…..
27. Lewy Body Dementia Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lewy Body Dementia Treatment Market Size, Share, Growth Analysis, Business Insights And Forecast To 2033 here

News-ID: 3601568 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Lewy

Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Lewy Body Dementia Market? In recent times, the market size for Lewy body dementia has witnessed substantial growth. It is projected to increase from $1.12 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key companies such as Cognition Therapeutics, Eli Lilly and Company, Athira Pharma, and NLS Pharmaceutics. The LBD pipeline features therapies targeting alpha-synuclein, neuroprotective agents, and symptomatic treatments that address cognition, motor symptoms, and neuropsychiatric complications. With no approved disease-modifying treatment, this pipeline represents a vital frontier
Lewy Body Dementia Treatment Market Challenges: Growth, Share, Value, Trends and …
Lewy Body Dementia Treatment Market Size And Forecast by 2031 The LBD Therapy Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Neurodegenerative Disorder Treatment Market are prioritizing digital transformation, product development, and data-driven decision-making to stay competitive. With rising investments in automation and efficiency, the Dementia Care Market is evolving to meet changing customer preferences.
Lewy Body Dementia Market Forecast 2025-2034: Evaluating Growth Factors, Segment …
How Are the key drivers contributing to the expansion of the lewy body dementia market? The growing prevalence of brain-related disorders is expected to boost the growth of the Lewy body dementia (LBD) market in the future. Brain-related disorders encompass various conditions that affect the brain's structure and function, leading to cognitive decline, memory loss, and behavioral changes. The prevalence of brain-related disorders is rising due to factors such as aging,
Lewy Body Dementia Treatment Market Focuses on Advancements in Diagnosis and The …
Global Lewy Body Dementia Treatment Market, By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, and Modafinil), Application Type (Parkinson's Disease and Alzheimer's Disease), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies and Others) - Industry Trends and Forecast to 2031. Data Bridge Market Research analyses that the Global Lewy Body Dementia Treatment Market which was USD 5.66 Billion in 2023
Lewy Body Dementia Treatment Market Analysis, Trends & Forecast 2024-2033 | Grow …
The lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to supportive care and family education, regulatory approvals and guideline, multidisciplinary care approaches, psychosocial and behavioral interventions, multidisciplinary care approaches.. The lewy body dementia treatment